175 related articles for article (PubMed ID: 627333)
1. The serum glucose response to glucagon suppression with somatostatin, insulin or antiglucagon serum in depancreatized rats.
Dunbar JC; Walsh MF; Foà PP
Diabetologia; 1978 Jan; 14(1):53-8. PubMed ID: 627333
[TBL] [Abstract][Full Text] [Related]
2. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
[TBL] [Abstract][Full Text] [Related]
3. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
Ross G; Lickley L; Vranic M
Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of somatostatin in regulating pancreatic splenic lobe hormone secretion following 99% pancreatectomy in adult chickens.
Cieslak SR; Hazelwood RL
Gen Comp Endocrinol; 1986 Aug; 63(2):284-94. PubMed ID: 2877920
[TBL] [Abstract][Full Text] [Related]
5. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
[TBL] [Abstract][Full Text] [Related]
6. The role of glucagon deficiency in the Houssay phenomenon of dogs.
Nakabayashi H; Dobbs RE; Unger RH
J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
[TBL] [Abstract][Full Text] [Related]
7. Failure of somatostatin to decrease blood glucose by suppression of extrapancreatic glucagon in severely diabetic depancreatized dogs.
Matsuyama T; Tanaka R; Shima K; Tarui S
Endocrinol Jpn; 1978 Dec; 25(6):529-32. PubMed ID: 751798
[TBL] [Abstract][Full Text] [Related]
8. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
Lickley HL; Kemmer FW; Doi K; Vranic M
Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
[TBL] [Abstract][Full Text] [Related]
9. Reversal of somatostatin inhibition of insulin and glucagon secretion.
Bhathena SJ; Perrino PV; Voyles NR; Smith SS; Wilkins SD; Coy DH; Schally AV; Recant L
Diabetes; 1976 Nov; 25(11):1031-40. PubMed ID: 992224
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive glucagon responses to oral glucose, insulin infusion and deprivation, and somatostatin in pancreatectomized man.
Werner PL; Palmer JP
Diabetes; 1978 Oct; 27(10):1005-12. PubMed ID: 700256
[TBL] [Abstract][Full Text] [Related]
11. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
[TBL] [Abstract][Full Text] [Related]
12. The role of the splenic pancreatic lobe in regulating metabolic normalcy following 99% pancreatectomy in chickens.
Cieslak SR; Hazelwood RL
Gen Comp Endocrinol; 1986 Mar; 61(3):476-89. PubMed ID: 2870006
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective insulin or glucagon deficiency on glucose turnover.
Lickley HL; Ross GG; Vranic M
Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
[TBL] [Abstract][Full Text] [Related]
14. Effect of adrenergic agents on the secretion of gastrointestinal immunoreactive glucagon in depancreatized dogs.
Yoshida T; Kondo M
Diabetes; 1980 May; 29(5):355-60. PubMed ID: 6103854
[TBL] [Abstract][Full Text] [Related]
15. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.
Patel YC; Pierzchala I; Amherdt M; Orci L
J Clin Invest; 1985 Apr; 75(4):1249-55. PubMed ID: 2859301
[TBL] [Abstract][Full Text] [Related]
16. Studies on persistent circulating immunoreactive glucagon (IRG) and immunoreactive insulin (IRI) found in eviscerated rats with a functional liver.
Smith SS; Bhathena SJ; Nompleggi D; Penhos JC; Recant L
Diabetologia; 1978 Mar; 14(3):177-84. PubMed ID: 658634
[No Abstract] [Full Text] [Related]
17. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
[TBL] [Abstract][Full Text] [Related]
18. Measurement and partial characterization of immunoreactive glucagon in gastrointestinal tissues of dogs.
Morita S; Doi K; Yip CC; Vranic M
Diabetes; 1976 Nov; 25(11):1018-25. PubMed ID: 186345
[TBL] [Abstract][Full Text] [Related]
19. Persistence of immunoreactive insulin, glucagon and pancreatic polypeptide in the plasma of depancreatized chickens.
Colca JR; Hazelwood RL
J Endocrinol; 1982 Mar; 92(3):317-26. PubMed ID: 7040582
[TBL] [Abstract][Full Text] [Related]
20. Gastric A-cell function in insulin-deprived depancreatized dogs.
Blazquez E; Muñoz-Barragan L; Patton GS; Orci L; Dobbs RE; Unger RH
Endocrinology; 1976 Nov; 99(5):1182-8. PubMed ID: 991814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
